Article Details
Retrieved on: 2021-05-11 21:46:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Boston-based synthetic biology leader Ginkgo Bioworks will go public via the SPAC company Soaring Eagle Acquisition. Why it matters: The deal ...
Article found on: news.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here